Immuneering Corp share price logo

Immuneering Corp Share Price

NASDAQ: IMRX

Small Cap

$5.58

+0.04

(+0.81%)

as on

Immuneering Corp Stock Performance

as on October 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $5.36
    $5.65
    downward going graph

    3.94%

    Downside

    1.25%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.1
    $10.08
    downward going graph

    80.29%

    Downside

    80.65%

    Upside

    downward going graph

Immuneering Corp share price movements today

Previous Close
$5.54
Open
$5.57
Volume
1.3M
Day's Low - High
$5.36 - $5.65
52 Week Low - High
$1.1 - $10.08

Immuneering Corp Historical Returns

1 Month Return
-38.07 %
3 Month Return
+ 35.11 %
1 Year Return
+ 149.11 %
3 Year Return
-57.63 %
5 Year Return
0 %

Immuneering Corp Stock Fundamentals & Key Indicators

Check Immuneering Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$350.3M

EPS (TTM)

-1.602

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.67

Industry PE ratio

0

PEG Ratio

0

EBITDA

-63.7M

Revenue (TTM)

455.0

Profit Margin

0.00%

Return On Equity TTM

46271000.00%

Immuneering Corp Stock Valuation

Track how Immuneering Corp P/E has moved over time to understand its valuation trends.

Immuneering Corp in the last 5 years

  • Overview

  • Trends

Lowest (-6.47x)

December 31, 2021

Industry (0.00x)

October 18, 2025

Today (-0.67x)

October 18, 2025

Highest (-0.71x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.67x

Immuneering Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immuneering Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$350.3MNA-0.670.00%
BUY$63.1B231.27%-505.15-12.96%
NA$36.7BNANA-3.89%
BUY$104.8B91.13%29.0431.86%
BUY$60.3B-3.62%14.3531.37%

Stock Returns calculator for Immuneering Corp Stock including INR - Dollar returns

The Immuneering Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Immuneering Corp investment value today

Current value as on today

₹2,53,902

Returns

₹1,53,902

(+153.9%)

Returns from Immuneering Corp Stock

₹1,49,107 (+149.11%)

Dollar Returns*

₹4,794 (+4.79%)

Analyst Recommendation on Immuneering Corp Stock

Based on 14 analysts

BUY

71.43%

Buy

28.57%

Hold

0.00%

Sell

Based on 14 analysts, 71.43% of analysts recommend a 'BUY' rating for Immuneering Corp. Average target price of $16.6

Immuneering Corp Share Price Target

Get share price movements and forecasts by analysts on Immuneering Corp.

What analysts predicted

66.39%UPSIDE

Target Price

$16.6

Current Price

$5.58

Analyzed by

14 Analysts

Target

$16.60

Immuneering Corp target price $16.6, a slight upside of 66.39% compared to current price of $5.58. According to 14 analysts rating.

Immuneering Corp Stock’s Investor Sentiment and Interest

Search interest for Immuneering Corp Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-31% versus previous 30 day period

Immuneering Corp Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
94
-
-94
-
-
-
0
-
-
Gross Profit
0
94
0
-94
0
0
0
0
0
0
Operating Income
-14
-13
-13
-16
-15
-14
-15
-18
-15
-14
EBITDA
-14
-13
-13
-14
-15
-14
-15
-18
-15
-14
Interest Expense
1,075
-
-
1,075
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-13
-12
-12
-15
-14
-14
-14
-18
-15
-14
Income Tax Expense
-1,075
-1
-13,912
0
0
0
0
0
-
-
Net Income
1,061
-12
-12
-15
-14
-14
-14
-18
-15
-14
Net Profit Margin
0.00%
-12.91%
0.00%
15.98%
0.00%
0.00%
0.00%
-2485.31%
0.00%
0.00%

Immuneering Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
1
2
2
0
0
-
Gross Profit
0
1
0
0
0
0
Operating Income
-6
-17
-33
-51
-58
-64
EBITDA
-7
-17
-33
-51
-58
-63
Interest Expense
0
0
0
1
-
-
Depreciation
0
0
0
0
0
0
Income Before Tax
-7
-17
-33
-50
-53
-61
Income Tax Expense
0
0
0
-1
0
-
Net Income
-8
-17
-33
-49
-53
-61
Net Profit Margin
-419.89%
-737.17%
-1612.33%
-15548.66%
-11752004.84%
0.00%

Immuneering Corp Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-12
-12
-15
-14
-14
-14
-18
-15
-14
Operating Cash Flow
-10
-12
-11
-15
-11
-13
-14
-14
-9
Investing Cash Flow
9
-23
3
21
4
-5
5
0
0
Financing Cash Flow
28
0
0
0
-
4
0
13
0
Change in Cash
26
-35
-8
6
-6
-14
-9
0
-9

Immuneering Corp Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-17
-33
-50
-53
-61
Operating Cash Flow
-14
-30
-44
-48
-54
Investing Cash Flow
0
-75
41
7
26
Financing Cash Flow
37
144
0
28
5
Change in Cash
23
37
-2
-13
-23

Global Institutional Holdings in Immuneering Corp

Funds
Holdings
Vanguard Group Inc
2.48%
Marshall Wace Asset Management Ltd
1.35%
BlackRock Inc
0.99%
SOUTHPORT MANAGEMENT, L.L.C.
0.57%
Geode Capital Management, LLC
0.54%

Immuneering Corp News & Key Events

  • img

    Today's Timeline - 30 September

    Tue, 09:12 PM

    -

    Mizuho reaffirms Outperform rating for Immuneering, maintaining $10 price target after positive Phase 2a trial results.

    Wed, 07:52 AM

    -

    Director Peter Feinberg invests $35,900 in Immuneering, reflecting confidence amid significant public offering and promising clinical trial data.

Insights on Immuneering Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -18.05M → -14.43M (in $), with an average increase of 12.1% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, -94.41M → 726.32K (in $), with an average increase of 13099.5% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, IMRX has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 150.9% return, outperforming this stock by 208.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, IMRX stock has moved down by -9.0%

About Immuneering Corp

Immuneering Corporation is a clinical-stage oncology company. The Company is engaged in the development of medicines for cancer patients with universal-RAS therapy. The Company’s lead product candidate, IMM-1-104, is in under Phase I/IIa clinical trial in patients with advanced solid tumors harboring RAS mutations. IMM-1-104 is being developed as a once-daily oral monotherapy that aims to achieve universal-RAS activity through deep cyclic inhibition of the mitogen-activated protein kinase (MAPK) pathway. The Company’s second product candidate, IMM-6-415, is an oral, twice-daily deep cyclic inhibitor of mitogen-activated protein kinase kinase (MEK) in a Phase I/IIa trial in patients with advanced solid tumors harboring RAS or RAF mutations. Its pipeline also includes RAS modulators and other small molecule drug discovery programs. The Company’s platform is enabled by two key elements: Bioinformatics and 3D Tumor Modeling.
OrganisationImmuneering Corp
Headquarters245 Main Street, Cambridge, MA, United States, 02142
CEODr. Benjamin J. Zeskind M.B.A., Ph.D.
E-voting on sharesClick here to vote

Key Management of Immuneering Corp

Name

Title

Mr. Robert J. Carpenter M.B.A., M.S.

Co-Founder & Chair Emeritus

Dr. Brett M. Hall Ph.D.

Chief Scientific Officer

Ms. Mallory Morales CPA

Principal Financial & Accounting Officer, Chief Accounting Officer and Treasurer

Ms. Leah R. Neufeld

Chief People Officer

Dr. Benjamin J. Zeskind M.B.A., Ph.D.

Co-Founder, President, CEO & Director

Mr. Michael D. Bookman J.D.

Chief Legal Officer & Secretary

Ms. Paula George CPA

Director of Accounting & Operations and Assistant Corporate Controller

Dr. Peter King Ph.D.

Head of Discovery & VP

Dr. Praveen Nair Ph.D.

Head of Translational Pharmacology & VP

Mr. Harold E. Brakewood

Chief Business Officer

FAQs

What is Immuneering Corp share price today?

Immuneering Corp share price today is $5.58 as on at the close of the market. Immuneering Corp share today touched a day high of $5.65 and a low of $5.36.

What is the 52 week high and 52 week low for Immuneering Corp share?

Immuneering Corp share touched a 52 week high of $10.08 on and a 52 week low of $1.1 on . Immuneering Corp stock price today i.e. is closed at $5.58,which is 44.64% down from its 52 week high and 407.27% up from its 52 week low.

What is Immuneering Corp's market capitalisation today?

Immuneering Corp market capitalisation is $0.00T as on .

How to invest in Immuneering Corp Stock (IMRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immuneering Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immuneering Corp Shares that will get you 0.2688 shares as per Immuneering Corp share price of $5.58 per share as on October 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Immuneering Corp Stock (IMRX) from India?

Indian investors can start investing in Immuneering Corp (IMRX) shares with as little as ₹87.954 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in Immuneering Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Immuneering Corp share’s latest price of $5.58 as on October 18, 2025 at 1:29 am IST, you will get 1.7921 shares of Immuneering Corp. Learn more about fractional shares .